Chan Soon-Shiong Institute for Medicine

Clinical research site in El Segundo, California

As of July 2026, 2 paid clinical trials are recruiting at Chan Soon-Shiong Institute for Medicine in El Segundo, California. Active studies at this site cover conditions such as NSCLC Stage IV and Platinum-resistant Ovarian Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Chan Soon-Shiong Institute for Medicine (2)

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

for NSCLC Stage IV

19 locations incl. Springdale

Sponsor: ImmunityBio, Inc.

Sex: All·Age: 18 - 90

Code: NCT06745908·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

for Platinum-resistant Ovarian Cancer

2 locations incl. El Segundo

Sponsor: ImmunityBio, Inc.

Sex: Female·Age: 18 - 85

Code: NCT06710288·Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

More research sites in El Segundo

CBCC Global Research (1 trial)
Chan Soon-Schiong Institute for Medicine (CSSIFM) (1 trial)

Explore more

Paid clinical trials in El Segundo, CA · California clinical trials